Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking

Nat Neurosci. 2022 Sep;25(9):1179-1190. doi: 10.1038/s41593-022-01135-0. Epub 2022 Aug 18.

Abstract

Repeated exposure to opioids causes tolerance, which limits their analgesic utility and contributes to overdose and abuse liability. However, the molecular mechanisms underpinning tolerance are not well understood. Here, we used a forward genetic screen in Caenorhabditis elegans for unbiased identification of genes regulating opioid tolerance which revealed a role for PTR-25/Ptchd1. We found that PTR-25/Ptchd1 controls μ-opioid receptor trafficking and that these effects were mediated by the ability of PTR-25/Ptchd1 to control membrane cholesterol content. Electrophysiological studies showed that loss of Ptchd1 in mice reduced opioid-induced desensitization of neurons in several brain regions and the peripheral nervous system. Mice and C. elegans lacking Ptchd1/PTR-25 display similarly augmented responses to opioids. Ptchd1 knockout mice fail to develop analgesic tolerance and have greatly diminished somatic withdrawal. Thus, we propose that Ptchd1 plays an evolutionarily conserved role in protecting the μ-opioid receptor against overstimulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid* / pharmacology
  • Animals
  • Caenorhabditis elegans
  • Cholesterol
  • Drug Tolerance
  • Membrane Proteins
  • Mice
  • Mice, Knockout
  • Morphine* / pharmacology
  • Receptors, Opioid, mu / genetics

Substances

  • Analgesics, Opioid
  • Membrane Proteins
  • Ptchd1 protein, mouse
  • Receptors, Opioid, mu
  • Morphine
  • Cholesterol